1. Home
  2. BODI vs CASI Comparison

BODI vs CASI Comparison

Compare BODI & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BODI
  • CASI
  • Stock Information
  • Founded
  • BODI 1998
  • CASI 1991
  • Country
  • BODI United States
  • CASI China
  • Employees
  • BODI N/A
  • CASI N/A
  • Industry
  • BODI Industrial Machinery/Components
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • BODI Industrials
  • CASI Health Care
  • Exchange
  • BODI Nasdaq
  • CASI Nasdaq
  • Market Cap
  • BODI 25.4M
  • CASI 20.5M
  • IPO Year
  • BODI N/A
  • CASI 1996
  • Fundamental
  • Price
  • BODI $3.91
  • CASI $1.29
  • Analyst Decision
  • BODI Buy
  • CASI Strong Buy
  • Analyst Count
  • BODI 2
  • CASI 1
  • Target Price
  • BODI $10.00
  • CASI $4.00
  • AVG Volume (30 Days)
  • BODI 13.1K
  • CASI 79.1K
  • Earning Date
  • BODI 08-05-2025
  • CASI 08-15-2025
  • Dividend Yield
  • BODI N/A
  • CASI N/A
  • EPS Growth
  • BODI N/A
  • CASI N/A
  • EPS
  • BODI N/A
  • CASI N/A
  • Revenue
  • BODI $371,113,000.00
  • CASI $31,368,000.00
  • Revenue This Year
  • BODI N/A
  • CASI N/A
  • Revenue Next Year
  • BODI N/A
  • CASI N/A
  • P/E Ratio
  • BODI N/A
  • CASI N/A
  • Revenue Growth
  • BODI N/A
  • CASI 8.39
  • 52 Week Low
  • BODI $3.38
  • CASI $1.09
  • 52 Week High
  • BODI $8.71
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • BODI 42.07
  • CASI 42.66
  • Support Level
  • BODI $4.30
  • CASI $1.21
  • Resistance Level
  • BODI $4.79
  • CASI $1.77
  • Average True Range (ATR)
  • BODI 0.32
  • CASI 0.13
  • MACD
  • BODI -0.01
  • CASI 0.01
  • Stochastic Oscillator
  • BODI 8.93
  • CASI 14.29

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: